Potential protective value of enhanced myocardial carbohydrate utilisation with reduced free fatty acid uptake after UK 25842 in patients with coronary artery disease [proceedings].
作者信息
Atkinson L, Bergman G, Jackson N, Jewitt D E, Metcalfe J M
出版信息
Br J Pharmacol. 1979 Jul;66(3):444P.
Abstract
摘要
相似文献
1
2
Change in myocardial metabolism in man by a new stimulator of carbohydrate oxidation.一种新型碳水化合物氧化刺激剂对人体心肌代谢的影响。
Res Commun Chem Pathol Pharmacol. 1979 Dec;26(3):459-67.
3
Myocardial substrate utilization and amino acid metabolism in chronic coronary artery disease.慢性冠状动脉疾病中的心肌底物利用和氨基酸代谢
Z Kardiol. 1987;76 Suppl 5:19-25.
4
Cardiac metabolism in myocardial ischaemia.心肌缺血中的心脏代谢
Ann Clin Res. 1977 Jun;9(3):102-11.
5
6
7
[Effect of ischemic state on myocardial utilization of nonesterified fatty acids].
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR. 1987;10(2):6-12.
8
Beneficial effect of enhanced myocardial carbohydrate utilisation after oxfenicine (L-hydroxyphenylglycine) in angina pectoris.奥昔非君（L-羟基苯甘氨酸）后心肌碳水化合物利用增强对心绞痛的有益作用。
Eur Heart J. 1980 Aug;1(4):247-53. doi: 10.1093/oxfordjournals.eurheartj.a061126.
9
Myocardial triacylglycerol metabolism in ischemia.
Tex Rep Biol Med. 1979;39:439-52.
10
Effects of pacing-induced ischemia on myocardial free fatty acid extractions.起搏诱导的缺血对心肌游离脂肪酸摄取的影响。
Clin Invest Med. 1979;2(1):23-7.
引用本文的文献
1
Changes in myocardial substrate utilisation and protection of ischemic stressed myocardium by oxfenicine [(S)-4-hydroxyphenylglycine].
Naunyn Schmiedebergs Arch Pharmacol. 1984 Aug;327(1):70-4. doi: 10.1007/BF00504994.
Zotero 插件